[Federal Register Volume 68, Number 239 (Friday, December 12, 2003)]
[Notices]
[Page 69422]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-30735]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Industrial Macromolecular Crystallography 
Association (``IMCA'')

    Notice is hereby given that, on November 17, 2003, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993--Industrial Macromolecular Crystallography Association (IMCA) has 
filed written notifications simultaneously with the Attorney General 
and the Federal Trade Commission disclosing changes in its membership 
status. The notifications were filed for the purpose of extending the 
Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Specifically, Novartis 
Institute for Biomedical Research, Inc., Cambridge, MA has been added 
as a party to this venture. Also, The Procter and Gamble Distributing 
Company, Cincinnati, OH; Pharmacia Corporation, Peapack, NJ; Pharmacia 
and Upjohn Company, Peapack, NJ; and Glaxo Wellcome Inc., Research 
Triangle Park, NC have been dropped as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and IMCA intends to file additional 
written notification disclosing all changes in membership.
    On October 23, 1990, IMCA filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to section 6(b) of the Act on 
December 3, 1990 (55 FR 49953).
    The last notification was filed with the Department on July 18, 
2000. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on May 23, 2001 (66 FR 28546).

Dorothy B. Fountain,
Deputy Director of Operations Antitrust Division.
[FR Doc. 03-30735 Filed 12-11-03; 8:45 am]
BILLING CODE 4410-11-M